Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled ""New LEQSELVIr (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026"".